Nadolol (Cipla USA Inc.)
Welcome to the PulseAid listing for the Nadolol drug offered from Cipla USA Inc.. This Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Cipla USA Inc. |
NON-PROPRIETARY NAME: | Nadolol |
SUBSTANCE NAME: | NADOLOL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-02-23 |
END MARKETING DATE: | 0000-00-00 |
Nadolol HUMAN PRESCRIPTION DRUG Details:
Item Description | Nadolol from Cipla USA Inc. |
LABELER NAME: | Cipla USA Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20(mg/1) |
START MARKETING DATE: | 2016-02-23 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69097-867_4d401693-53ab-4d63-9f25-39fe5ddca2a1 |
PRODUCT NDC: | 69097-867 |
APPLICATION NUMBER: | ANDA203455 |
Other NADOLOL Pharmaceutical Manufacturers / Labelers: